Ki67- protein: a proliferation index in breast cancer

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Reviews in Clinical Medicine

• Publication date

  2015-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.17463/RCM.2015.04.010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• [Prognostic value of ki-67 and vimentin markers in patients with metastatic kidney cancer].

  2014cited by this paper
• [Prognostic value of ki-67 and vimentin markers in patients with metastatic kidney cancer].

  2014cited by this paper
• Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.

  2013cited by this paper
• Clinical impact of ki-67 labeling index in non-small cell lung cancer.

  2013cited by this paper
• Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

  2013cited by this paper
• Ki-67 Labeling Index as an Adjunct in the Diagnosis of Serous Tubal Intraepithelial Carcinoma

  2012cited by this paper
• Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer.

  2011cited by this paper
• Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer.

  2009cited by this paper
• The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

  2009cited by this paper
• Outcome Prediction for Estrogen Receptor–Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics

  2008cited by this paper
• Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

  2008cited by this paper
• Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

  2008cited by this paper
• Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast

  2008cited by this paper
• Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

  2008cited by this paper
• The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma

  2004cited by this paper
• Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells.

  2004cited by this paper
• Ki-67 Proliferation Index: Correlation With Prognostic Parameters and Outcome in Multiple Myeloma

  2004cited by this paper
• Granular cell tumor: immunohistochemical assessment of inhibin-alpha, protein gene product 9.5, S100 protein, CD68, and Ki-67 proliferative index with clinical correlation.

  2004cited by this paper
• Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: correlation with clinical outcome.

  2002cited by this paper
• Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.

  2001cited by this paper
• The murine Ki-67 cell proliferation antigen accumulates in the nucleolar and heterochromatic regions of interphase cells and at the periphery of the mitotic chromosomes in a process essential for cell cycle progression.

  1996cited by this paper
• Monoclonal antibodies Ki‐S3 and Ki‐S5 yield new data on the ‘Ki‐67’proteins

  1996cited by this paper
• Assessing cellular proliferation: what's worth measuring?

  1995cited by this paper
• Review : Assessing cellular proliferation: what's worth measuring?

  1995cited by this paper
• The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins

  1993cited by this paper
• Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections

  1992cited by this paper
• Assignment of the human Ki-67 gene (MKI67) to 10q25−qter

  1991cited by this paper
• Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

  1983cited by this paper

• Lamin A/C as a biomarker for breast cancer

  2025cites this paper
• STANDARDIZATION OF KI-67 AS A BIOMARKER OF CELL PROLIFERATION

  2019cites this paper
• Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients

  2018cites this paper
• Classification of Proteins Expression in some Popular Cancers for Protein Biomarkers Identification

  2018cites this paper
• The Potential for Individualization of Neoadjuvant Chemotherapy in Breast Cancer

  2018cites this paper
• Study of KI 67 expression in carcinoma breast

  2017cites this paper